Patents by Inventor Malcolm Roy Brandon

Malcolm Roy Brandon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110217366
    Abstract: The present invention provides an immunopotentiating composition which comprises an antigen or antigen-inducing substance, and a carrier comprising a biocompatible material for effectively increasing an immune response derived from an antigen. The present invention further provides a method of producing an antibody by administering said immunopotentiating composition to a mammal or bird, thereby modulating the immune response in said mammal or bird and recovering the antibody produced.
    Type: Application
    Filed: May 17, 2011
    Publication date: September 8, 2011
    Applicants: Dainippon Sumitomo Pharma Co., Ltd., The University of Melbourne, KONEN CO., LTD.
    Inventors: Keiji FUJIOKA, Akihiko Sano, Shunji Nagahara, Malcolm Roy Brandon, Andrew Donald Nash, Shari Lofthouse
  • Patent number: 7598082
    Abstract: This invention relates to the reprogramming of animal cells and animal cell nuclei by nuclear addition. The invention also relates to the generation of animal cells, cell lines, tissues, organs, embryos and non-human animals by methods involving nuclear addition.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: October 6, 2009
    Assignee: Stem Cell Sciences (Australia) Pty Ltd
    Inventors: Malcolm Roy Brandon, Andrew James French, Hongwu Chan, Peter Mountford, Megan Jayne Munsie
  • Patent number: 5747290
    Abstract: A process for producing recombinant polypeptides having porcine growth hormone activity, by culturing unicellular organisms containing synthetic DNA sequences coding for such polypeptides and expressing and recovering the polypeptides is described. The recombinant polypeptides may be used in animals in veterinary compositions as effective substitutes for natually derived porcine growth hormone. Recombinant DNA processes for the preparation of the unicellular organisms are also described.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 5, 1998
    Assignee: Southern Cross Biotech Party, Ltd
    Inventors: John Spencer Emtage, Malcolm Roy Brandon
  • Patent number: 5650154
    Abstract: Methods and kits for identifying antigens from a pathogen. The antigens identified are preferably those that provide protection for an animal against the pathogen. The steps of the method include providing a sample of the pathogen, isolating the protective antigen from the sample of antigen with an antibody probe. The antibody probe is produced by obtaining a biological sample containing antibody producing cells from an immune animal infected with or challenged by the pathogen or pathogen extract, and obtaining the antibodies from these cells by culturing the cells. These methods and kits are useful for preparing antigens to be used as vaccines, in diagnostic kits, and to prepare polyclonal or monoclonal antibodies.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: July 22, 1997
    Inventors: Elza Nicole Theresia Meeusen, Malcolm Roy Brandon, Vernon Morrison Bowles, John Walker, Mark Douglas Gorrell